ChemicalBook > CAS DataBase List > (1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one

Product Name
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
CAS No.
1186587-53-0
Chemical Name
(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
Synonyms
Paricalcitol-2;Paricalcitol Impurity AS;Paricalcitol lmpurity 42;(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one;(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one;4H-Inden-4-one, octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-, (1R,3aR,7aR)-;Paricalcitol impurity 2/(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
CBNumber
CB33377063
Molecular Formula
C19H32O2
Formula Weight
292.46
MOL File
1186587-53-0.mol
More
Less

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Property

Boiling point:
400.4±18.0 °C(Predicted)
Density 
0.992±0.06 g/cm3(Predicted)
pka
14.93±0.29(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
O236460
Product name
(1R,3aR,7aR)-Octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-one
Packaging
10mg
Price
$2600
Updated
2021/12/16
More
Less

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Chemical Properties,Usage,Production

Uses

(1R,3aR,7aR)-Octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-one is a useful synthetic intermediate in the synthesis of 22Z-vitamin D’s. One example is 22Z-Paricalcitol (P195320); the 22Z-isomer of Paricalcitol (P195300) which is a synthetic analog of vitamin D and an antihyperparathyroid.

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one Suppliers

China 22 India 1 United States 1 Global 24
Beijing Comparison Pharmaceutical Technology Co., Ltd
Tel
010-010-52878169 15801002657
Email
sales@bjcomparison.com
Country
China
ProdList
4989
Advantage
58
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15178
Advantage
58
Shandong Juntai Pharmaceutical Co., LTD.
Tel
15853135817
Fax
0531-66958526
Email
sales@h2opharm.com
Country
China
ProdList
162
Advantage
55
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@qq.com
Country
China
ProdList
8377
Advantage
55
Anhui Feixiang Pharmaceutical Technology Co., Ltd.
Tel
13349001619
Email
sales@feixiangpharm.com
Country
China
ProdList
1008
Advantage
58
Hangzhou Huarong Pharm Co., Ltd.
Tel
571-86758373 +8613588754946
Fax
0086-571-81131109
Email
sales@huarongpharm.com
Country
CHINA
ProdList
3148
Advantage
58
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 17825480238
Fax
QQ 3008233717
Email
3008233717@qq.com
Country
China
ProdList
9919
Advantage
12
Standardpharm Co. Ltd.
Tel
86-714-3992388
Email
overseasales1@yongstandards.com
Country
United States
ProdList
14332
Advantage
58
Jinan blalong chemical co. LTD
Tel
2710913286@.com
Email
1513643261@qq.com
Country
China
ProdList
14246
Advantage
58
Shanghai Payne Pharmaceutical Technology Co.Ltd
Tel
021-58123769 17721400256
Email
info@paynepharm.com
Country
China
ProdList
1285
Advantage
58

1186587-53-0, (1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-oneRelated Search:

2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol 2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol PL-A':(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one PL-AS':(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimeth ylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one benzyl (4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl) carbamate 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine (3S,6R,E)-6-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis ((tert-butyldimethylsilyl)oxy)cyclohexylidene) ethylidene)-7a-methyloctahydro-1H-inden-1-yl)- 2,3-dimethylhept-4-en-2-ol (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy- 5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H- inden-4-ylidene)ethylidene)cyclohexane-1,3-diol tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl -6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl) -7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((trimethylsilyl)oxy)hept-3-en-2-yl)-7a- methyloctahydro-4H-inden-4-one 1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- (1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one

  • (1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
  • (1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
  • Paricalcitol-2
  • Paricalcitol impurity 2/(1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one
  • 4H-Inden-4-one, octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-, (1R,3aR,7aR)-
  • Paricalcitol lmpurity 42
  • Paricalcitol Impurity AS
  • 1186587-53-0